Abstract
This is the first article in a four-part series on new radiopharmaceuticals. Upon completion of this article, the nuclear medicine technologist will be able to (1) give an overview of the new radiopharmaceuticals developed over the last five years, (2) list and compare the new radiotracers used to image the heart and the brain, and (3) identify the newer agents being utilized for therapy.